Zobrazeno 1 - 10
of 556
pro vyhledávání: '"Cevreska, L."'
Autor:
Popova-Labachevska M, Panovska-Stavridis I, Eftimov A, Kapedanovska Nestorovska A, Cevreska L, Ivanovski M, Ridova N, Trajkova S, Dimovski AJ
Publikováno v:
Balkan Journal of Medical Genetics, Vol 22, Iss 2, Pp 31-36 (2019)
The identification of the JAK2V617F mutation in several distinct myeloproliferative neoplasms (MPNs) raised the question how one single mutation incites expression of at least three different clinical phenotypes, i.e., polycythemia vera (PV), essenti
Externí odkaz:
https://doaj.org/article/2c38d23238de4936b1da294fbf181777
Autor:
Panovska-Stavridis I.1 dr_irina@yahoo.com, Cevreska L.1
Publikováno v:
Contributions of Macedonian Academy of Sciences & Arts. 2013, Vol. 34 Issue 1, p67-74. 8p.
Autor:
Panovska-Stavridis, I.1 dr_irina@yahoo.com, Cevreska, L.1, Ivanovski, M.1, Stojanovik, A.1, Lozance, M.1, Matevska, N.2, Dimovski, A.2, Serafimoski, V.1
Publikováno v:
Contributions of Macedonian Academy of Sciences & Arts. 2008, Vol. 29 Issue 2, p257-267. 11p. 1 Chart, 1 Graph.
Publikováno v:
J Clin Oncol.
PURPOSE: Rituximab maintenance therapy has been shown to improve progression free survival in patients with follicular lymphoma; however the optimal duration of maintenance treatment remains unknown. PATIENTS AND METHODS: Two hundred seventy patients
Autor:
Moccia AA; Oncology Institute of Southern Switzerland, Medical Oncology Clinic, Ospedale San Giovanni, Bellinzona, Switzerland., Taverna C; Medical Oncology, Kantonsspital Münsterlingen, Münsterlingen, Switzerland., Schär S; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland., Vanazzi A; Istituto Europeo di Oncologia, European Institute of Oncology Istituti di Ricovero e Cura a Carattere Scientifico, Milan, Italy., Rondeau S; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland., Hitz F; Kantonsspital Saint Gallen, Saint Gallen, Switzerland., Mingrone W; Kantonsspital Olten, Olten, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland., Cevreska L; University Clinic for Hematology, Skopje, Macedonia., Del Giglio A; Hematology and Oncology, ABC Fondation School of Medicine, Sao Paulo, Brazil., Raats J; CancerCare Rondebosch, Cape Town, South Africa., Rauch D; Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland., Vorobiof DA; Institute Sandton Oncology Center, Johannesburg, South Africa., Lohri A; Department of Oncology/Hematology, Kantonsspital Baselland, Liestal, Switzerland; and., Ruegsegger C; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland., Biaggi Rudolf C; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland., Rusterholz C; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland., Hayoz S; Swiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland., Ghielmini M; Oncology Institute of Southern Switzerland, Medical Oncology Clinic, Ospedale San Giovanni, Bellinzona, Switzerland., Zucca E; Oncology Institute of Southern Switzerland, Medical Oncology Clinic, Ospedale San Giovanni, Bellinzona, Switzerland.; Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
Publikováno v:
Blood advances [Blood Adv] 2020 Dec 08; Vol. 4 (23), pp. 5951-5957.
Autor:
Panovska-Stavridis I; University Clinic of Hematology-Skopje, RN Macedonia., Pivkova-Veljanovska A; University Clinic of Hematology-Skopje, RN Macedonia., Ridova N; University Clinic of Hematology-Skopje, RN Macedonia., Stojanovski Z; University Clinic of Hematology-Skopje, RN Macedonia., Cadievski L; University Clinic of Hematology-Skopje, RN Macedonia., Trajkova S; University Clinic of Hematology-Skopje, RN Macedonia., Popova-Labacevska M; University Clinic of Hematology-Skopje, RN Macedonia., Matevska-Geshkovska N; Center for Biomolecular Pharmaceutical Analyses, UKIM -Faculty of Pharmacy, University 'Ss Cyril and Methodius', Skopje, RN Macedonia., Cevreska L; University Clinic of Hematology-Skopje, RN Macedonia., Georgievski B; University Clinic of Hematology-Skopje, RN Macedonia., Dimovski A; Center for Biomolecular Pharmaceutical Analyses, UKIM -Faculty of Pharmacy, University 'Ss Cyril and Methodius', Skopje, RN Macedonia.; Research Center for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, RN Macedonia.
Publikováno v:
Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) [Pril (Makedon Akad Nauk Umet Odd Med Nauki)] 2020 Dec 08; Vol. 41 (3), pp. 5-12. Date of Electronic Publication: 2020 Dec 08.
Publikováno v:
Europe PubMed Central
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease characterized by thrombocytopenia due to the presence of platelet autoantibodies specific for platelet membrane glycoproteins, such as GPIIb/IIIa, GPIb/IX and GPIa/IIa. These autoanti
Autor:
Pavkovic M, Petrushevska G, Rubens Jovanovic, Karanfilski O, Cevreska L, Stankovic S, Stojanovic A
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Bisphosphonates are pyrophosphate analogues which inhibit osteoclastic activity. Long term use of bisphosphonates has recently been associated with osteonecrosis of the jaw (ONJ) defined as a three month non-healing defect in the jaw. ONJ is commonly
Autor:
Panovska-Stavridis I, Ivanovski M, Hadzi-Pecova L, Ljatifi A, Trajkov D, Mirko Spiroski, Cevreska L
Publikováno v:
Europe PubMed Central
A case of aggressive adult neuroblastoma mimicking acute leukemia with fulminant course and fatal outcome is described. Pancytopenia and circulating blasts cells at presentation suggested the diagnosis of acute leukemia in the previously healthy 38 y
Autor:
Veljanovska AP; University Clinic for Haematology, Bone Marrow Transplantation Unit, Medical faculty, University Ss. Cyril and Methodius,Skopje, Republic of Macedonia., Stojanoski Z; University Clinic for Haematology, Bone Marrow Transplantation Unit, Medical faculty, University Ss. Cyril and Methodius,Skopje, Republic of Macedonia., Chadievski L; University Clinic for Haematology, Bone Marrow Transplantation Unit, Medical faculty, University Ss. Cyril and Methodius,Skopje, Republic of Macedonia., Stavridis IP; University Clinic for Haematology, Bone Marrow Transplantation Unit, Medical faculty, University Ss. Cyril and Methodius,Skopje, Republic of Macedonia., Trajkova S; University Clinic for Haematology, Bone Marrow Transplantation Unit, Medical faculty, University Ss. Cyril and Methodius,Skopje, Republic of Macedonia., Cevreska L; University Clinic for Haematology, Bone Marrow Transplantation Unit, Medical faculty, University Ss. Cyril and Methodius,Skopje, Republic of Macedonia., Georgievski B; University Clinic for Haematology, Bone Marrow Transplantation Unit, Medical faculty, University Ss. Cyril and Methodius,Skopje, Republic of Macedonia.
Publikováno v:
Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) [Pril (Makedon Akad Nauk Umet Odd Med Nauki)] 2019 May 01; Vol. 40 (1), pp. 81-86.